Schmidt Ulrike, Ryan Elizabeth G, Bartholdy Savani, Renwick Bethany, Keyes Alexandra, O'Hara Caitlin, McClelland Jessica, Lose Anna, Kenyon Martha, Dejong Hannah, Broadbent Hannah, Loomes Rachel, Serpell Lucy, Richards Lorna, Johnson-Sabine Eric, Boughton Nicky, Whitehead Linette, Bonin Eva, Beecham Jennifer, Landau Sabine, Treasure Janet
Department of Psychological Medicine, King's College London, Institute of Psychiatry, Psychology and Neuroscience, London, United Kingdom.
Department of Biostatistics, Kings College London, Institute of Psychiatry, Psychology and Neuroscience, London, United Kingdom.
Int J Eat Disord. 2016 Aug;49(8):793-800. doi: 10.1002/eat.22523. Epub 2016 Apr 6.
This study reports follow-up data from a multicenter randomized controlled trial (n = 142) comparing the Maudsley Model of Anorexia Nervosa Treatment for Adults (MANTRA) with Specialist Supportive Clinical Management (SSCM) in outpatients with broadly defined anorexia nervosa (AN). At 12 months postrandomization, all patients had statistically significant improvements in body mass index (BMI), eating disorder (ED) symptomatology and other outcomes with no differences between groups. MANTRA was more acceptable to patients. The present study assessed whether gains were maintained at 24 months postrandomization.
Follow-up data at 24 months were obtained from 73.2% of participants. Outcome measures included BMI, ED symptomatology, distress, impairment, and additional service utilization during the study period. Outcomes were analyzed using linear mixed models.
There were few differences between groups. In both treatment groups, improvements in BMI, ED symptomatology, distress levels, and clinical impairment were maintained or increased further. Estimated mean BMI change from baseline to 24 months was 2.16 kg/m(2) for SSCM and 2.25 kg/m(2) for MANTRA (effect sizes of 1.75 and 1.83, respectively). Most participants (83%) did not require any additional intensive treatments (e.g., hospitalization). Two SSCM patients became overweight through binge-eating.
Both treatments have value as outpatient interventions for patients with AN. © 2016 Crown copyright. International Journal of Eating Disorders. (Int J Eat Disord 2016; 49:793-800).
本研究报告了一项多中心随机对照试验(n = 142)的随访数据,该试验比较了成人神经性厌食症莫兹利治疗模式(MANTRA)与专科支持性临床管理(SSCM)对广义神经性厌食症(AN)门诊患者的疗效。随机分组后12个月时,所有患者的体重指数(BMI)、饮食失调(ED)症状及其他指标均有统计学意义上的显著改善,两组间无差异。MANTRA更易被患者接受。本研究评估了随机分组后24个月时这些改善是否得以维持。
从73.2%的参与者处获得了24个月时的随访数据。结局指标包括BMI、ED症状、痛苦程度、功能损害以及研究期间的额外服务利用情况。采用线性混合模型分析结局数据。
两组间差异不大。在两个治疗组中,BMI、ED症状、痛苦程度及临床功能损害的改善均得以维持或进一步提高。从基线到24个月,SSCM组BMI估计平均变化为2.16 kg/m²,MANTRA组为2.25 kg/m²(效应量分别为1.75和1.83)。大多数参与者(83%)无需任何额外的强化治疗(如住院治疗)。两名接受SSCM治疗的患者因暴饮暴食而超重。
两种治疗方法作为AN患者的门诊干预措施均有价值。© 2016英国政府版权。《国际进食障碍杂志》。(《国际进食障碍杂志》2016年;49:793 - 800)